CHELMSFORD, Mass., April 13, 2020 /PRNewswire/ -- Brooks
Automation, Inc. (Nasdaq: BRKS) today reported preliminary
financial results for the second fiscal quarter of 2020, ended
March 31, 2020.
Second Quarter FY2020 Preliminary Unaudited Financial
Results
- Total revenue of approximately $220
million, up 11% YtY and 5% sequentially
- Semiconductor revenue of approximately $125 million, up 11% YtY and 5% sequentially
- Life Sciences revenue of approximately $95 million, up 11% YtY and 4% sequentially
- GAAP EPS between $0.11 and
$0.13 per diluted share
- Non-GAAP EPS between $0.24 and
$0.26 per diluted share
The company also reported that all of its facilities remained
operational during the COVID-19 crisis with only required personnel
on site, and the balance of employees working from home. The
Company has implemented CDC social distancing guidelines and other
best practices to ensure the health and safety of its
employees. In the Life Sciences business, GENEWIZ and Sample
Management operations are taking orders for all its offerings while
fast tracking those in support of research and development related
to the COVID-19 virus. The Semiconductor Solutions business
continues to supply critical chip manufacturing equipment and
support services globally. Both of the Company's business
segments fall within an "Essential Critical Infrastructure Sector"
as defined by the U.S. Department of Homeland Security, which have
a special responsibility to continue operations during the COVID-19
crisis.
Second Quarter FY2020 Earnings Conference Call and
Webcast
Additionally, the Company announced that it plans to
announce its fiscal 2020 second quarter earnings results which
ended March 31, 2020,
on Thursday, April 30, 2020 after the market
closes. The Company will host a conference call and live
webcast to discuss its financial results on the same
day, Thursday, April 30, 2020 at 4:30 p.m. Eastern
Time. To participate in the conference call, please dial
800-906-5924 for domestic callers and +1-212-231-2904 for
international callers. Analysts and investors can access the
live webcast via the Brooks website at
www.brooks.investorroom.com/events. A replay will be
available beginning at 8:30 a.m. ET on May 1,
2020.
Needham Virtual Healthcare Conference Webcast
As
previously announced, Brooks management will be presenting at the
19th Annual Needham Virtual Healthcare Conference on
Tuesday, April 14, 2020 at
10:40am. Steve Schwartz, President and CEO, and
Lindon Robertson, Executive Vice
President and CFO, will present an overview of the company and an
update on the current business environment. The presentation
will be webcast live in listen-only mode. The live webcast and
replay will be available on the Brooks website at
www.brooks.investorroom.com.
Regulation G – Use of Non-GAAP financial Measures
The
Company supplements its GAAP financial measures with certain
non-GAAP financial measures to provide investors a better
perspective on the results of business operations, which the
Company believes is more comparable to the similar analysis
provided by its peers. These measures are not presented in
accordance with, nor are they a substitute for, U.S. generally
accepted accounting principles, or GAAP. These measures should
always be considered in conjunction with appropriate GAAP measures.
Adjustments to GAAP results include the impact of amortization of
intangible assets, restructuring charges, purchase price accounting
adjustments and charges related to M&A. Management also
excludes special charges and gains, such as impairment losses,
gains and losses from the sale of assets, as well as other gains
and charges that are not representative of the normal operations of
the business. These measures should always be considered in
conjunction with appropriate GAAP measures. The company has
not provided a reconciliation of the estimated non-GAAP financial
measure to its comparable GAAP financial measure because it could
not produce the corresponding GAAP financial measure by the date of
this press release without unreasonable effort. A reconciliation of
non-GAAP measures to the most nearly comparable GAAP measures will
be provided when the Company reports its full results for the
quarter ended March 31, 2020.
"Safe Harbor Statement" under Section 21E of the Securities
Exchange Act of 1934
Some statements in this release are
forward-looking statements made under Section 21E of the Securities
Exchange Act of 1934. These statements are neither promises nor
guarantees but involve risks and uncertainties, both known and
unknown, that could cause Brooks' financial and business results to
differ materially from our expectations. They are based on the
facts known to management at the time they are made. These
forward-looking statements include but are not limited to
statements about our preliminary revenue and earnings results.
Factors that could cause results to differ from our expectations
include the following: the volatility of the industries the
Company serves, particularly the semiconductor industry; our
possible inability to meet demand for our products due to
difficulties in obtaining components and materials from our
suppliers in required quantities and of required quality; risks and
uncertainties related to the coronavirus originating in
Wuhan, China and its effects on
the Company's operations in China,
including supply chain, and the operations of our customers in
China; the inability of customers
to make payments to us when due; the timing and effectiveness of
cost reduction and cost control measures; price competition;
disputes concerning intellectual property; uncertainties in global
political and economic conditions, and other factors and other
risks, including those that we have described in our filings with
the Securities and Exchange Commission, including but not limited
to our Annual Report on Form 10-K, current reports on Form 8-K and
our quarterly reports on Form 10-Q. In addition, actual financial
results may differ from the preliminary financial results indicated
herein as a result of the completion of our financial statements
for the quarter ended March 31, 2020
as well as other risks and uncertainties, including those
referenced above. As a result, we can provide no assurance that our
future results will not be materially different from those
projected. Brooks expressly disclaims any obligation or undertaking
to release publicly any updates or revisions to any such statement
to reflect any change in our expectations or any change in events,
conditions or circumstances on which any such statement is based.
Brooks undertakes no obligation to update the information contained
in this press release.
About Brooks Automation
Brooks (Nasdaq: BRKS) is a
leading provider of life science sample-based solutions and
semiconductor manufacturing solutions worldwide. The
Company's Life Sciences business provides a full suite of reliable
cold-chain sample management solutions and genomic services across
areas such as drug development, clinical research and advanced cell
therapies for the industry's top pharmaceutical, biotech, academic
and healthcare institutions globally. Brooks Life Sciences'
GENEWIZ division is a leading provider of DNA gene sequencing and
gene synthesis services. With over 40 years as a partner to
the semiconductor manufacturing industry, Brooks is a provider of
industry-leading precision vacuum robotics, integrated automation
systems and contamination control solutions to the world's leading
semiconductor chip makers and equipment manufacturers. Brooks
is headquartered in Chelmsford,
MA, with operations in North
America, Europe and
Asia. For more information, visit www.brooks.com.
INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/brooks-automation-reports-preliminary-results-for-its-second-quarter-of-fiscal-2020-ended-march-31-2020-and-timing-of-its-second-quarter-conference-call-and-webcast-301039592.html
SOURCE Brooks Automation